JP2012521366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012521366A5 JP2012521366A5 JP2012501089A JP2012501089A JP2012521366A5 JP 2012521366 A5 JP2012521366 A5 JP 2012521366A5 JP 2012501089 A JP2012501089 A JP 2012501089A JP 2012501089 A JP2012501089 A JP 2012501089A JP 2012521366 A5 JP2012521366 A5 JP 2012521366A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- purified
- use according
- klk1
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000605522 Homo sapiens Kallikrein-1 Proteins 0.000 claims 15
- 102100038297 Kallikrein-1 Human genes 0.000 claims 15
- 239000012634 fragment Substances 0.000 claims 7
- FYSKZKQBTVLYEQ-FSLKYBNLSA-N Kallidin Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 FYSKZKQBTVLYEQ-FSLKYBNLSA-N 0.000 claims 5
- 108010003195 Kallidin Proteins 0.000 claims 5
- 108010058188 Low-Molecular-Weight Kininogen Proteins 0.000 claims 5
- 102000012479 Serine Proteases Human genes 0.000 claims 5
- 108010022999 Serine Proteases Proteins 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 230000003820 β-cell dysfunction Effects 0.000 claims 4
- 150000001413 amino acids Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims 1
- 230000006320 pegylation Effects 0.000 claims 1
- 238000010188 recombinant method Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16317309P | 2009-03-25 | 2009-03-25 | |
| US61/163,173 | 2009-03-25 | ||
| PCT/CA2010/000413 WO2010108262A1 (en) | 2009-03-25 | 2010-03-25 | TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC β-CELL DYSFUNCTION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012521366A JP2012521366A (ja) | 2012-09-13 |
| JP2012521366A5 true JP2012521366A5 (enExample) | 2013-05-09 |
Family
ID=42780097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012501089A Pending JP2012521366A (ja) | 2009-03-25 | 2010-03-25 | 膵臓β細胞機能不全の治療のための組織カリクレイン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120070425A1 (enExample) |
| EP (1) | EP2411042A4 (enExample) |
| JP (1) | JP2012521366A (enExample) |
| CN (1) | CN102438648A (enExample) |
| AU (1) | AU2010228068A1 (enExample) |
| CA (1) | CA2756801A1 (enExample) |
| NZ (1) | NZ595364A (enExample) |
| WO (1) | WO2010108262A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8501695B2 (en) | 2007-07-20 | 2013-08-06 | Diamedica, Inc. | Tissue kallikrein for the treatment of diseases associated with amyloid protein |
| JP2014520119A (ja) * | 2011-06-17 | 2014-08-21 | ザ・ジョンズ・ホプキンス・ユニバーシティー | インスリン感受性を増大させる方法および糖尿病を処置するための方法 |
| US20130315891A1 (en) | 2012-05-25 | 2013-11-28 | Matthew Charles | Formulations of human tissue kallikrein-1 for parenteral delivery and related methods |
| CA2880085C (en) | 2012-06-04 | 2021-09-07 | Diamedica Inc. | Human tissue kallikrein 1 glycosylation isoforms |
| CN109498815B (zh) * | 2013-12-30 | 2022-07-22 | 江苏众红生物工程创药研究院有限公司 | 重组人激肽释放酶的化学修饰物及其应用 |
| EP3592377A4 (en) | 2017-03-09 | 2021-02-17 | Diamedica Inc. | TISSUE KALLICREIN DOSAGE FORMS 1 |
| CN112481268B (zh) * | 2021-01-25 | 2024-01-30 | 河南大学 | 一种棉花启动子PGhPGF及其重组载体和应用 |
| CN116135973A (zh) * | 2021-11-16 | 2023-05-19 | 江苏众红生物工程创药研究院有限公司 | 低糖基化修饰的激肽原酶及其聚乙二醇修饰物和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534615A (en) | 1994-04-25 | 1996-07-09 | Genentech, Inc. | Cardiac hypertrophy factor and uses therefor |
| EP1079792A2 (en) * | 1998-05-22 | 2001-03-07 | EntreMed, Inc. | Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| CN1228447C (zh) * | 2001-02-20 | 2005-11-23 | 深圳市人民医院 | 一种含有人胰腺组织激肽释放酶成熟蛋白基因的重组表达载体 |
| CN100338212C (zh) * | 2003-01-29 | 2007-09-19 | 中国科学院大连化学物理研究所 | 人组织激肽释放酶的微囊化细胞及其微囊化方法和应用 |
| WO2006017538A2 (en) * | 2004-08-03 | 2006-02-16 | Dyax Corp. | Hk1-binding proteins |
| CN101094869A (zh) * | 2004-08-03 | 2007-12-26 | 戴埃克斯有限公司 | Hk1结合蛋白 |
| JP2009544630A (ja) * | 2006-07-26 | 2009-12-17 | デイアメデイカ・インコーポレイテツド | 代謝障害の診断及び治療方法 |
| US7625944B2 (en) * | 2006-07-31 | 2009-12-01 | Activesite Pharmaceuticals, Inc. | Inhibitors of plasma kallikrein |
| CN101134953B (zh) * | 2007-07-02 | 2011-02-09 | 广东天普生化医药股份有限公司 | 重组人胰激肽原酶 |
| CN101255438B (zh) * | 2008-04-11 | 2012-01-25 | 深圳大学 | 表达人组织激肽释放酶的转基因莱茵衣藻的构建方法 |
-
2010
- 2010-03-25 NZ NZ595364A patent/NZ595364A/xx not_active IP Right Cessation
- 2010-03-25 EP EP10755352A patent/EP2411042A4/en not_active Ceased
- 2010-03-25 AU AU2010228068A patent/AU2010228068A1/en not_active Abandoned
- 2010-03-25 CA CA2756801A patent/CA2756801A1/en not_active Abandoned
- 2010-03-25 JP JP2012501089A patent/JP2012521366A/ja active Pending
- 2010-03-25 WO PCT/CA2010/000413 patent/WO2010108262A1/en not_active Ceased
- 2010-03-25 CN CN2010800181825A patent/CN102438648A/zh active Pending
-
2011
- 2011-09-23 US US13/241,882 patent/US20120070425A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012521366A5 (enExample) | ||
| NZ627372A (en) | Clostridium histolyticum enzymes and methods for the use thereof | |
| RU2013151875A (ru) | Модифицированная кислая альфа глюкозидаза с ускоренным процессингом | |
| JP2014513952A5 (enExample) | ||
| JP2012176978A5 (enExample) | ||
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| NZ597306A (en) | Mesenchymal stem cell differentiation | |
| NZ602845A (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| MX2012008999A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012009000A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| JP2012530073A5 (enExample) | ||
| NZ596823A (en) | Swine influenza hemagglutinin variants | |
| IN2012DN02981A (enExample) | ||
| RU2006145899A (ru) | Ферменты для фармацевтического применения | |
| JP2014506450A5 (enExample) | ||
| CY1118856T1 (el) | Εμβολιο pcsk9 | |
| NZ610620A (en) | Inhibitors of apoptosis and uses thereof | |
| RU2015118580A (ru) | НОВЫЙ ВЫСОКО ФУНКЦИОНАЛЬНЫЙ ФЕРМЕНТ, ИМЕЮЩИЙ МОДИФИЦИРОВАННУЮ СУБСТРАТНУЮ СПЕЦИФИЧНОСТЬ β-ГЕКСОЗАМИНИДАЗЫ ЧЕЛОВЕКА И ПРОЯВЛЯЮЩИЙ УСТОЙЧИВОСТЬ К ПРОТЕАЗЕ | |
| JP2017511133A (ja) | 新規の方法、ポリペプチド、及びその使用 | |
| NZ703514A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| NZ614557A (en) | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use | |
| RU2008102738A (ru) | Протеазы для фармацевтического применения | |
| JP2013504519A5 (enExample) | ||
| JP2009544304A5 (enExample) |